Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2007, Vol. 110, No. 6, pp. 1711-1712.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLeo, F. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DeLeo, F. R.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

CHEMOKINES

Comment on Chalaris et al, page 1748

Attractive shedding

Frank R. DeLeo

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID)

In this issue of Blood, Chalaris and colleagues show that ADAM17 regulates shedding of interleukin-6 receptor (IL-6R) by apoptotic neutrophils, a process critical for IL-6 trans-signaling in the switch from neutrophil to mononuclear leukocyte recruitment during the resolution of inflammation.

The inflammatory response is characterized largely by influx of neutrophils. These phagocytes possess extraordinary microbicidal capacity and are thus efficient at killing invading microorganisms. On the other hand, cytotoxic molecules of neutrophils have potential to cause significant host tissue damage if released during cell lysis. To avoid this problem, neutrophils undergo apoptosis following phagocytosis as a mechanism to promote resolution of inflammation (see figure). The resolution process also includes switching from neutrophil to mononuclear leukocyte recruitment, and mononuclear phagocytes are responsible for removal of apoptotic neutrophils.1 The switch in leukocyte recruitment involves IL-6 trans-signaling,2 but a trigger for this process has remained elusive.

IL-6 is a cytokine that signals through a receptor system consisting of IL-6R, an 80-kDa transmembrane protein that binds IL-6, and a signal transducer molecule known as gp130.2,3 Binding of IL-6 by IL-6R/gp130 ultimately leads to activation of STAT3 and gene transcription in the nucleus.2,3 Expression of IL-6R is restricted to hepatocytes, neutrophils, mononuclear phagocytes, and other leukocytes, whereas gp130 is expressed ubiquitously.3,4 IL-6 can elicit responses directly in cells expressing IL-6R/gp130 or, alternatively, a soluble form of IL-6R (sIL-6R) can bind IL-6 and the complex can be recognized by cells expressing gp130 alone. This process is known as IL-6 trans-signaling.24 sIL-6R is generated by shedding (proteolytic cleavage from the cell surface) or from alternatively spliced mRNA.3 There are several known inducers of IL-6R shedding, including bacterial pore-forming toxins, phorbol ester, and metalloproteinases such as ADAM17.

New studies by Chalaris and colleagues reveal that apoptosis is a trigger for IL-6R shedding. Using murine pre-B cells that express human IL-6R, the authors demonstrated that induction of apoptosis by doxorubicin or cytokine withdrawal caused release of IL-6R, thereby forming sIL-6R. Release of IL-6R occurred during early apoptosis and was mediated by the metalloproteinase ADAM17. Next, the authors used HepG2 cells to show that shedding of IL-6R can be mediated by ligation of Fas (CD95), an extrinsic apoptosis pathway stimulus, and that release of IL-6R is caspase-dependent. These results led to a final series of experiments using human neutrophils and a mouse model of acute inflammation. IL-6R was shed from apoptotic human neutrophils in an ADAM17-dependent manner, consistent with recent studies by Walcheck et al.5 Using a mouse model of acute inflammation, the authors discovered that shedding of IL-6R by neutrophils in vivo was essential for subsequent recruitment of mononuclear phagocytes.

These studies extend previous findings by identifying (1) an impetus for the release of IL-6R during inflammation and (2) the signal for recruitment of mononuclear phagocytes and subsequent removal of apoptotic neutrophils during the resolution of acute inflammation (see figure). Given its importance in this process, the IL-6R system is a likely target for new therapeutics designed to treat inflammatory disorders.3


Figure 1
View larger version (63K):
[in this window]
[in a new window]

 
IL-6 trans-signaling in the resolution of inflammation. The inflammatory response involves influx of polymorphonuclear leukocytes (PMNs or neutrophils). Phagocytosis of microbes and cell activation ultimately lead to PMN apoptosis (a-PMN), during which ADAM17 is activated to cleave IL-6R from the cell surface (shedding). IL-6 and soluble IL-6R derived from neutrophils signal recruitment of mononuclear phagocytes by IL-6 trans-signaling, possibly through endothelial cells. Phagocytosis of apoptotic neutrophils by mononuclear phagocytes, typically macrophages (M{varphi}), is a key step in the resolution of acute inflammation.

 

Footnotes

Support for this article was provided by the Intramural Research Program of the NIAID, National Institutes of Health.

Conflict-of-interest disclosure: The author declares no competing financial interests. {blacksquare}

REFERENCES

  1. Savill JS, Wyllie AH, Henson JE, et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83:865–867.[Medline] [Order article via Infotrieve]

  2. Hurst SM, Wilkinson TS, McLoughlin RM, et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14:705–714.[CrossRef][Medline] [Order article via Infotrieve]

  3. Nishimoto N and Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2007; 2:619–626.[CrossRef]

  4. Rose-John S, Waetzig GH, Scheller J, et al. The IL-6/sIL6R complex as a novel target for therapeuitic apparoches. Expert Opin Ther Targets 2007; 11:613–624.[CrossRef][Medline] [Order article via Infotrieve]

  5. Walcheck B, Herrera AH, Saint Hill C, et al. ADAM17 activity during human neutrophil activation and apoptosis. Eur J Immunol 2006; 36:968–976.[CrossRef][Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils
Athena Chalaris, Björn Rabe, Krzysztof Paliga, Hans Lange, Tamas Laskay, Ceri A. Fielding, Simon A. Jones, Stefan Rose-John, and Jürgen Scheller
Blood 2007 110: 1748-1755. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLeo, F. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DeLeo, F. R.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020